Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K

K. Kalinsky, W. Zihan, C. McCourt, E. P. Mitchell, J. J. Wright, L. A. Doyle, R. J. Gray, V. Wang, L. M. McShane, L. V. Rubinstein, D. Patton, P. M. Williams, S. R. Hamilton, B. A. Conley, C. A. Arteaga, L. N. Harris, P. J. O'Dwyer, A. P. Chen, K. T. Flaherty

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)S8-S9
JournalEuropean Journal of Cancer
StatePublished - Oct 2022

Cite this